SHANDONG XINHUA Pharmaceutical Company Limited has called an Extraordinary General Meeting (EGM) for 10 November 2026 at 2:00 p.m. in its Zibo, Shandong headquarters. The sole agenda item is an ordinary resolution to appoint Mr. Liu Weimin as an executive director. If approved, Liu’s mandate will run from the EGM date until the current Board’s term ends on 21 December 2026.
The shareholder register for H shares will be closed from 3 November to 10 November 2026, inclusive. Investors intending to attend the meeting must ensure their share transfers are lodged with Computershare Hong Kong Investor Services by 4:30 p.m. on 2 November 2026. Reply slips confirming attendance should reach either the Board Secretary’s office in Zibo or the Hong Kong share registrar by 2:00 p.m. on 9 November 2026.
Shareholders of record as of the close of business on 3 November 2026—both on the Hong Kong register and the Shenzhen register—are eligible to participate. Proxy appointments must be filed no later than 24 hours before the EGM’s start time.
The current Board comprises Chairman He Tongqing, Executive Directors Xu Wenhui and Hou Ning, Non-executive Director Zhang Chengyong, and four Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue and Cheung Ching Ching (Daisy).
The EGM is expected to last half a day; attendees will bear their own travel and accommodation costs.
Comments